Submitted by Anonymous (not verified) on 27 May 2026 - 11:08
Human medicines European public assessment report (EPAR): Trumenba, meningococcal group b vaccine (recombinant, adsorbed), Date of authorisation: 24/05/2017, Revision: 23, Status: Authorised
Source: